Cited by 20Thyroid Disorders and TreatmentsHormonal and reproductive studiesHeart Failure Treatment and Management

Nonthyroidal Illness Syndrome and Hypothyroidism in Ischemic Heart Disease Population: A Systematic Review and Meta-Analysis

Chang, Chun-Yu, Chien, Yung-Jiun, Lin, Po-Chen, Chen, Chien-Sheng, Wu, Meng-Yu·2020·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: The association of non-thyroidal illness syndrome (NTIS) and hypothyroidism with the prognosis in ischemic heart disease (IHD) population is inconclusive. Objective: We aimed to evaluate the influence of NTIS and hypothyroidism on all-cause mortality and major adverse cardiac events (MACE) in IHD population. Data Sources: We searched PubMed, EMBASE, Scopus, Web of Science, and Cochrane Library from inception through February 17, 2020. Study Selection: Original articles enrolling IHD patients, comparing all-cause mortality and MACE of NTIS and hypothyroidism with those of euthyroidism, and providing sufficient information for meta-analysis were considered eligible. Data Extraction: Relevant information and numerical data were extracted for methodological assessment and meta-analysis. Data Synthesis: Twenty-three studies were included. The IHD population with NTIS was associated with higher risk of all-cause mortality (hazard ratio [HR] = 2.61; 95% confidence interval [CI] = 1.89-3.59) and MACE (HR = 2.22; 95% CI = 1.71-2.89) than that without. In addition, the IHD population with hypothyroidism was also associated with higher risk of all-cause mortality (HR = 1.47; 95% CI = 1.10-1.97) and MACE (HR = 1.53; 95% CI = 1.19-1.97) than that without. In the subgroup analysis, the acute coronary syndrome (ACS) subpopulation with NTIS was associated with higher risk of all-cause mortality (HR = 3.30; 95% CI = 2.43-4.48) and MACE (HR = 2.19; 95% CI = 1.45-3.30). The ACS subpopulation with hypothyroidism was also associated with higher risk of all-cause mortality (HR = 1.67; 95% CI = 1.17-2.39). Conclusions: The IHD population with concomitant NTIS or hypothyroidism was associated with higher risk of all-cause mortality and MACE. Future research is required to provide evidence of the causal relationship and to elucidate whether normalizing thyroid function parameters can improve prognosis.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa310

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In patients with ischemic heart disease, hypothyroidism (both subclinical and overt) is associated with a higher risk of all-cause mortality (HR = 1.47; 95% CI = 1.10-1.97, p = 0.009).

    “The authors included 7 studies in their analysis, showing that hypothyroidism (both subclinical and overt) was associated with a higher risk of all-cause mortality (HR = 1.47; 95% CI = 1.10–1.97, p = 0.009) and MACE (HR = 1.53, CI = 1.19–1.97; p < 0.001).”

    From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [29]

  • In patients with ischemic heart disease, hypothyroidism (both subclinical and overt) is associated with a higher risk of MACE (HR = 1.53, CI = 1.19-1.97; p < 0.001).

    “The authors included 7 studies in their analysis, showing that hypothyroidism (both subclinical and overt) was associated with a higher risk of all-cause mortality (HR = 1.47; 95% CI = 1.10–1.97, p = 0.009) and MACE (HR = 1.53, CI = 1.19–1.97; p < 0.001).”

    From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [29]

  • In the 3 studies separately analyzing overt versus subclinical hypothyroidism, there were no significant differences for overall mortality or MACE between euthyroid and subclinical hypothyroid patients.

    “However, the 3 studies separately analyzing the impact of overt versus SC-HT reported no significant differences for overall mortality or MACE between euthyroid and subclinical hypothyroid patients [29].”

    From Thyroid and heart, a clinically relevant relationship (2021) · cites this paper as [29]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chang, C.-Y., Chien, Y.-J., Lin, P.-C., Chen, C.-S., & Wu, M.-Y.
Affiliations
  • Tzu Chi University (TW)
  • Taipei Tzu Chi Hospital (TW)
Corresponding author
Wu, Meng-Yu
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-05-27
Volume
105
Issue
8
Pages
2830-2845
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3030861532
Cited by
20
References
72
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 1
FWCI
0.54
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
Taipei Tzu Chi Hospital (TCRD-TPE-109-02, TCRD-TPE-109-03)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
low T3 syndrome, hypothyroidism, ischemic heart disease, all-cause mortality, major adverse cardiac events, acute coronary syndrome, prognosis, euthyroidism, thyroid function
MeSH terms
Cause of Death, Euthyroid Sick Syndromes, Humans, Hypothyroidism, Prognosis, Risk Factors, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review